Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis (Cancer Cell, 2024)

(untitled) - Gupta, T; Antanaviciute, A; Lee, CH-J; Ottakandathil Babu, R; Aulicino, A; Christoforidou, Z; Siejka-Zielinska, P; O'Brien-Ball, C; Chen, H; Fawkner-Corbett, D; Geros, AS; Bridges, E; et al.